Source: Isracann BioSciences
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • Isracann Biosciences (IPOT) has closed the first tranche of a non-brokered private placement for gross proceeds of $233,980
  • The company issued 4,679,600 units at $0.05 per unit
  • Each unit consists of one common share and one share purchase warrant
  • Isracann is a cannabis focused producer and product developer
  • Isracann Biosciences Inc. (IPOT) opened trading at C$0.05

Isracann Biosciences (IPOT) has closed the first tranche of a non-brokered private placement.

The company issued 4,679,600 units at $0.05 per unit for gross proceeds of $233,980. Each unit consists of one common share and one share purchase warrant. Each warrant entitles the holder to acquire one additional share for 48 months.

Net proceeds will be used to fund product development and for general operations.

All securities issued will be subject to a statutory four-month hold period ending on December 3, 2022.

Isracann is a cannabis focused producer and product developer with Israeli-based cannabis production farm assets and a Canadian natural health medicine development and production arm.

Isracann Biosciences Inc. (IPOT) opened trading at C$0.05.


More From The Market Herald
High Tide - CEO, Raj Grover.

" High Tide (TSXV:HITI) secures commitment for $19M credit facility

High Tide (HITI) has signed a binding commitment letter with Connect First Credit Union.
Avicanna Inc - CEO, Aras Azadian.

" Avicanna (TSX:AVCN) closes private placement

Avicanna (AVCN) has closed a non-brokered private placement for gross proceeds of approximately $2.782 million.

" Minnova (TSXV:MCI) closes first tranche of non-brokered private placement and provides corporate update

Minnova Corp. (MCI) has closed the first tranche of a non-brokered private placement for gross proceeds of $70,000.

" Simply Better Brands Corp. (TSXV:SBBC) closes second tranche of private placement

Simply Better Brands (SBBC) has closed the second tranche of a non-brokered private placement for gross proceeds of $1,018,999.62.